Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 254

1.

Surrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.

Rotolo F, Pignon JP, Bourhis J, Marguet S, Leclercq J, Tong Ng W, Ma J, Chan AT, Huang PY, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Soong YL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lee AW, Blanchard P, Michiels S; MAC-NPC Collaborative Group..

J Natl Cancer Inst. 2017 Apr;109(4). pii: djw239.

PMID:
27927756
2.

Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration.

Dourthe ME, Ternès N, Gajda D, Paci A, Dufour C, Benhamou E, Valteau-Couanet D.

Bone Marrow Transplant. 2016 Sep;51(9):1265-7. doi: 10.1038/bmt.2016.109. Epub 2016 Apr 25. No abstract available.

PMID:
27111042
3.

Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution.

Proust-Houdemont S, Pasqualini C, Blanchard P, Dufour C, Benhamou E, Goma G, Semeraro M, Raquin MA, Hartmann O, Valteau-Couanet D.

Bone Marrow Transplant. 2016 Aug;51(8):1076-81. doi: 10.1038/bmt.2016.75. Epub 2016 Apr 4.

PMID:
27042850
4.

Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial.

Borget I, Bonastre J, Catargi B, Déandréis D, Zerdoud S, Rusu D, Bardet S, Leenhardt L, Bastie D, Schvartz C, Vera P, Morel O, Benisvy D, Bournaud C, Bonichon F, Kelly A, Toubert ME, Leboulleux S, Journeau F, Benhamou E, Schlumberger M.

J Clin Oncol. 2015 Sep 10;33(26):2885-92. doi: 10.1200/JCO.2015.61.6722. Epub 2015 Aug 3.

PMID:
26240230
5.

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.

Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J, Pignon JP; MAC-NPC Collaborative Group..

Lancet Oncol. 2015 Jun;16(6):645-55. doi: 10.1016/S1470-2045(15)70126-9. Epub 2015 May 6.

PMID:
25957714
6.

Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.

Mallone S, De Angelis R, van der Zwan JM, Trama A, Siesling S, Gatta G, Capocaccia R; RARECARE WG..

Cancer Epidemiol. 2013 Dec;37(6):850-6. doi: 10.1016/j.canep.2013.08.001. Epub 2013 Sep 16.

PMID:
24050903
7.

Strategies of radioiodine ablation in patients with low-risk thyroid cancer.

Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, Bardet S, Leenhardt L, Bastie D, Schvartz C, Vera P, Morel O, Benisvy D, Bournaud C, Bonichon F, Dejax C, Toubert ME, Leboulleux S, Ricard M, Benhamou E; Tumeurs de la Thyroïde Refractaires Network for the Essai Stimulation Ablation Equivalence Trial..

N Engl J Med. 2012 May 3;366(18):1663-73. doi: 10.1056/NEJMoa1108586.

8.

Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe.

Trama A, Mallone S, Nicolai N, Necchi A, Schaapveld M, Gietema J, Znaor A, Ardanaz E, Berrino F; RARECARE Working Group..

Eur J Cancer. 2012 Jan;48(2):159-69. doi: 10.1016/j.ejca.2011.08.020. Epub 2011 Dec 3. Erratum in: Eur J Cancer. 2013 Feb;49(3):766.

PMID:
22142457
9.

Rare cancers are not so rare: the rare cancer burden in Europe.

Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R; RARECARE working group..

Eur J Cancer. 2011 Nov;47(17):2493-511. doi: 10.1016/j.ejca.2011.08.008. Epub 2011 Oct 25.

PMID:
22033323
10.

Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intent.

Tortochaux J, Tao Y, Tournay E, Lapeyre M, Lesaunier F, Bardet E, Janot F, Lusinchi A, Benhamou E, Bontemps P, Maingon P, Calais G, Daly-Schveitzer N, Verrelle P, Bourhis J.

Radiother Oncol. 2011 Jul;100(1):70-5. doi: 10.1016/j.radonc.2011.06.025. Epub 2011 Jul 7.

PMID:
21741720
11.

Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients.

Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Toubert ME, Torlontano M, Benhamou E, Schlumberger M; THYRDIAG Working Group..

J Clin Endocrinol Metab. 2011 May;96(5):1352-9. doi: 10.1210/jc.2010-2708. Epub 2011 Mar 9.

PMID:
21389143
12.

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study.

Journot V, Pignon JP, Gaultier C, Daurat V, Bouxin-Métro A, Giraudeau B, Preux PM, Tréluyer JM, Chevret S, Plättner V, Thalamas C, Clisant S, Ravaud P, Chêne G; Optimon Collaborative Group..

Contemp Clin Trials. 2011 Jan;32(1):16-24. doi: 10.1016/j.cct.2010.10.001. Epub 2010 Oct 14.

PMID:
20951234
13.

The burden of rare cancers in Europe.

Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group..

Adv Exp Med Biol. 2010;686:285-303. doi: 10.1007/978-90-481-9485-8_17. Review.

PMID:
20824452
14.

Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.

Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ, Hamoir M, Géry B, Julieron M, Castaing M, Bardet E, Grégoire V, Bourhis J.

J Clin Oncol. 2008 Dec 1;26(34):5518-23. doi: 10.1200/JCO.2007.15.0102. Epub 2008 Oct 20.

PMID:
18936479
15.

Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.

Cacchione A, LeMaitre A, Couanet DV, Benhamou E, Amoroso L, Simonnard N, Hartmann O.

Bone Marrow Transplant. 2008 Oct;42(7):449-54. doi: 10.1038/bmt.2008.186. Epub 2008 Jun 30.

PMID:
18587430
16.

Cancer incidence and mortality in France over the period 1980-2005.

Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinié F, Danzon A, Bara S, Bouvier AM, Trétarre B, Binder-Foucard F, Colonna M, Daubisse L, Hédelin G, Launoy G, Le Stang N, Maynadié M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Chérié-Challine L, Estève J, Remontet L, Velten M.

Rev Epidemiol Sante Publique. 2008 Jun;56(3):159-75. doi: 10.1016/j.respe.2008.03.117. Epub 2008 Jun 10.

PMID:
18547762
17.

Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.

Schlumberger M, Hitzel A, Toubert ME, Corone C, Troalen F, Schlageter MH, Claustrat F, Koscielny S, Taieb D, Toubeau M, Bonichon F, Borson-Chazot F, Leenhardt L, Schvartz C, Dejax C, Brenot-Rossi I, Torlontano M, Tenenbaum F, Bardet S, Bussière F, Girard JJ, Morel O, Schneegans O, Schlienger JL, Prost A, So D, Archambeaud F, Ricard M, Benhamou E.

J Clin Endocrinol Metab. 2007 Jul;92(7):2487-95. Epub 2007 Apr 10.

PMID:
17426102
18.

Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumors.

Bouligand J, Le Maitre A, Valteau-Couanet D, Grill J, Drouard-Troalen L, Paci A, Hartmann O, Benhamou E, Vassal G.

Clin Pharmacol Ther. 2007 Oct;82(4):402-9. Epub 2007 Mar 28.

PMID:
17392724
19.

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial.

Bourhis J, Lapeyre M, Tortochaux J, Rives M, Aghili M, Bourdin S, Lesaunier F, Benassi T, Lemanski C, Geoffrois L, Lusinchi A, Verrelle P, Bardet E, Julieron M, Wibault P, Luboinski M, Benhamou E.

J Clin Oncol. 2006 Jun 20;24(18):2873-8.

PMID:
16782926
20.

High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.

Valteau-Couanet D, Fillipini B, Benhamou E, Grill J, Kalifa C, Couanet D, Habrand JL, Hartmann O.

Bone Marrow Transplant. 2005 Dec;36(11):939-45.

PMID:
16184181

Supplemental Content

Loading ...
Support Center